Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Altimmune

ALT

ALT Altimmune NASDAQ
Add to watchlist
26.34
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    ALT Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume --
    • Turnover --
    • P/E(TTM) --
    • Turnover % --
    • P/E(Static) --
    • Market Cap --
    • P/B --
    • Shares --
    • 52 Week Range
    • Day Range

    About

    Altimmune, Inc. was incorporated on April 25, 2005 under the laws of the State of Delaware. The company is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The company lead product candidate,...
    • Highlight
      A company that develops medical products to stimulate robust and durable immune responses for the prevention
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      05/05/2017
    • Established Date
      04/25/2005
    • Full-time Employees
      59
    • Address
      910 Clopper Road Suite 201S Gaithersburg MD 20878
    • Tel
      1-240-6541450
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD